ChemBioChem · 2002 · 41 citations · 0 references
PharmacyBiochemistryMedicinal ChemistryDrug DesignDrug DiscoveryEnzymologyDe Novo Drug DesignEnzyme InhibitionEnzyme-substrate RecognitionLigand BindingMolecular DockingProtein-ligand DockingBinding Free EnergyBinding Mode PredictionBinding Pocket DesignDe Novo Enzyme DesignEnzyme Inhibitor DiscoveryProtein-ligand Binding Free EnergyStructure-based De Novo DesignSubstrate Binding Sites
A lipophilic pocket at the tRNA-guanine transglycosylase (TGT) enzyme active site was discovered and a substantial contribution to the substrate binding free energy was observed when this pocket was filled by apolar side chains. A family of new inhibitors of TGT was developed by employing the principles of molecular recognition and structure-based de novo design, and shown to display up to submicromolar binding affinity. Two X-ray structures of TGT–inhibitor complexes confirmed the binding mode predicted in the design stage. An exceptional ”point mutation” effect on binding affinity was observed upon substitution of X=CH2 in 1 with O or S.